NCT04174898View on ClinicalTrials.gov

MSC Infusion for Anti-aging and Regenerative Therapy

PHASE1UnknownINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

April 15, 2020

Primary Completion Date

April 14, 2021

Study Completion Date

April 14, 2022

Conditions
Aging WellRegenerative Medicine
Interventions
BIOLOGICAL

human Mesenchymal Stem Cell (MSC) infusion therapy

Subjects will be infused with 100million human MSCs

Trial Locations (1)

80000

Landmark Medical Centre Sdn Bhd, Johor Bahru

Sponsors
All Listed Sponsors
collaborator

CytoMed Therapeutics Pte Ltd

INDUSTRY

lead

Landmark Medical Centre Sdn Bhd

OTHER